查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1876580

植入式心臟監測器市場機會、成長促進因素、產業趨勢分析及預測（2025-2034年）

Implantable Cardiac Monitor Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034
出版日期: | 出版商: Global Market Insights Inc. | 英文 160 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2024 年全球植入式心臟監視器市場價值為 9.104 億美元，預計到 2034 年將以 6.3% 的複合年成長率成長至 17 億美元。

植入式心臟監測器市場 - IMG1

心血管疾病盛行率的上升、人口老化以及對持續遠端心臟監測需求的日益成長，正在推動市場擴張。遠端監測解決方案的技術進步也透過改善患者預後和實現及時干預，促進了市場成長。植入式心臟監測器為醫院、專科心臟中心、門診手術中心和醫療技術公司提供先進的解決方案，以早期檢測心律不整並簡化臨床工作流程。長期植入式循環記錄器、無線傳輸系統和遠端監測技術可實現持續的心律追蹤、早期診斷和個人化患者管理。隨著全球人口老化，慢性心血管疾病日益普遍，進一步增加了長期監測的需求。醫護人員和患者對早期心律不整檢測和持續監測的認知不斷提高，正在推動市場應用。小型化設備和無線連接也提高了患者的依從性和臨床效率。

市場範圍
起始年份 2024
預測年份 2025-2034
起始值 9.104億美元
預測值 17億美元
複合年成長率 6.3%

2024年，心房顫動細分市場佔據41.8%的市佔率。這一領先地位主要得益於心房顫動盛行率的上升、中風風險的增加以及對早期診斷的需求，這些因素使得持續植入式監測至關重要。心房顫動仍然是最常見的心律不整，尤其是在老年人和患有基礎心血管疾病的患者身上。透過長期監測進行早期發現有助於預防包括中風和心臟衰竭在內的嚴重併發症。

醫院板塊佔據52.7%的市場佔有率，預計在2025年至2034年間將達到9.037億美元。醫院之所以佔據主導地位，是因為擁有先進的基礎設施、專業的心臟科室以及能夠進行植入式手術的熟練醫護人員。住院患者中心律不整和心房顫動發生率的不斷上升，推動了持續監測的需求。與電子健康記錄和遠端監測平台的整合，進一步提高了醫院的效率和病患資料管理水準。

2024年，北美植入式心臟監測器市佔率達35.5%。該地區受益於老年人口中心血管疾病的高發生率、完善的醫療基礎設施以及覆蓋廣泛的醫院和專科心臟中心網路，這些機構均配備了植入式手術設備。小型化循環記錄器、無線監測系統和人工智慧驅動的預測分析等技術創新進一步推動了植入式心臟監測器的普及，這些創新能夠改善患者預後並提高營運效率。

植入式心臟監視器市場的主要參與者包括美敦力、Vectorious Medical Technologies、雅培、百多力、波士頓科學和AngelMed/Avertix。這些公司正透過加大研發投入，開發具備無線和遠端監護功能的微型化、節能型設備，從而鞏固其市場地位。許多公司正與醫院、心臟病中心和技術供應商建立策略合作關係，將植入式心臟監視器系統整合到臨床工作流程中。此外，各公司也正在拓展業務範圍和分銷網路，以進入新興市場。增強用於預測分析、人工智慧驅動的診斷和即時患者監護的軟體平台也是一項關鍵策略。

目錄

第1章：方法論與範圍

第2章：執行概要

第3章：行業洞察

  • 產業生態系分析
  • 產業影響因素
    • 成長促進因素
      • 心律不整和心房顫動的盛行率不斷上升
      • 遠端監控和連接技術的進步
      • 老年人口成長及其相關的心臟風險
      • 優惠的報銷政策和早期診斷計劃
    • 產業陷阱與挑戰
      • 設備和植入手術費用高昂
      • 患者和全科醫師的認知程度有限
    • 市場機遇
      • 與人工智慧和預測分析的整合
      • 開發智慧、小型化和長壽命設備
  • 成長潛力分析
  • 2024年定價分析
  • 2021-2034年植入式心臟監視器銷售量（單位：台）
    • 全球的
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • MEA
  • 監管環境
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
  • 技術進步
    • 當前技術趨勢
      • 用於長期心臟監測的微型植入式循環記錄儀
      • 可實現即時心律資料傳輸的遠端監測平台
      • 病人友善、微創的設備，可提高舒適度和手術效率
    • 新興技術
      • 人工智慧驅動的心律不整檢測和預測分析用於早期診斷
      • 整合智慧型手機和雲端平台的無線連接植入式心臟監視器
      • 具備自適應警報系統和自動臨床醫生通知功能的智慧型設備
  • 差距分析
  • 波特的分析
  • PESTEL 分析
  • 未來市場趨勢
    • 人工智慧、數位醫療和互聯心臟設備的融合
    • 擴大居家和門診心臟監測解決方案
    • 隨著新興市場醫療基礎設施的改善，其成長勢頭強勁。

第4章：競爭格局

  • 介紹
  • 公司矩陣分析
  • 公司市佔率分析
    • 全球的
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
  • 競爭定位矩陣
  • 主要市場參與者的競爭分析
  • 關鍵進展
    • 併購
    • 合作夥伴關係與合作
    • 新服務類型推出
    • 擴張計劃

第5章：市場估算與預測：依指示劑分類，2021-2034年

  • 主要趨勢
  • 心房顫動（心房顫動）
  • 心律不整
  • 心搏過緩
  • 心跳過速
  • 其他跡象

第6章：市場估算與預測：依最終用途分類，2021-2034年

  • 主要趨勢
  • 醫院
  • 專業心臟中心
  • 門診手術中心
  • 其他最終用途

第7章：市場估計與預測：依地區分類，2021-2034年

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第8章：公司簡介

  • Abbott
  • AngelMed / Avertix
  • BIOTRONIK
  • Boston Scientific
  • Medtronic
  • Vectorious Medical Technologies
簡介目錄
Product Code: 15145

The Global Implantable Cardiac Monitor Market was valued at USD 910.4 million in 2024 and is estimated to grow at a CAGR of 6.3% to reach USD 1.7 billion by 2034.

Implantable Cardiac Monitor Market - IMG1

The rising prevalence of cardiovascular diseases, an aging population, and the increasing need for continuous remote cardiac monitoring are driving market expansion. Technological advancements in remote monitoring solutions are also contributing to growth by enhancing patient outcomes and enabling timely intervention. Implantable cardiac monitors provide hospitals, specialized cardiac centers, ambulatory surgical facilities, and health technology companies with advanced solutions to detect arrhythmias early and streamline clinical workflows. Long-term implantable loop recorders, wireless transmission systems, and remote monitoring technologies allow continuous rhythm tracking, early diagnosis, and personalized patient management. With the global population aging, chronic cardiovascular conditions are becoming more common, further increasing demand for long-term monitoring. Greater awareness among healthcare providers and patients regarding early arrhythmia detection and continuous monitoring is boosting market adoption. Miniaturized devices and wireless connectivity have also improved patient compliance and clinical efficiency.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$910.4 Million
Forecast Value$1.7 Billion
CAGR6.3%

The atrial fibrillation segment held a 41.8% share in 2024. This leadership is driven by the rising prevalence of AF, heightened stroke risk, and demand for early diagnosis, which makes continuous implantable monitoring essential. Atrial fibrillation remains the most common cardiac arrhythmia, particularly among older adults and patients with underlying cardiovascular disorders. Early detection through long-term monitoring helps prevent serious complications, including stroke and heart failure.

The hospitals segment held a 52.7% share and is expected to reach USD 903.7 million during 2025-2034. Hospitals dominate because of their advanced infrastructure, specialized cardiology departments, and skilled personnel capable of performing implantable procedures. The increasing incidence of arrhythmias and atrial fibrillation among inpatients fuels demand for continuous monitoring. Integration with electronic health records and remote monitoring platforms further enhances hospital efficiency and patient data management.

North America Implantable Cardiac Monitor Market held a 35.5% share in 2024. The region benefits from a high prevalence of cardiovascular conditions among its elderly population, a well-established healthcare infrastructure, and an extensive network of hospitals and specialty cardiac centers equipped for implantable procedures. Adoption is further supported by technological innovations such as miniaturized loop recorders, wireless monitoring systems, and AI-driven predictive analytics, which enhance patient outcomes and improve operational efficiency.

Key players in the Implantable Cardiac Monitor Market include Medtronic, Vectorious Medical Technologies, Abbott, BIOTRONIK, Boston Scientific, and AngelMed / Avertix. Companies in the Implantable Cardiac Monitor Market are strengthening their presence by investing in R&D to develop miniaturized, energy-efficient devices with wireless and remote monitoring capabilities. Many are forming strategic collaborations with hospitals, cardiology centers, and technology providers to integrate their ICM systems into clinical workflows. Companies are also expanding their geographical footprint and distribution networks to access emerging markets. Enhancing software platforms for predictive analytics, AI-driven diagnostics, and real-time patient monitoring is another key strategy.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Data mining sources
    • 1.3.1 Global
    • 1.3.2 Regional/country
  • 1.4 Base estimates and calculations
    • 1.4.1 Base year calculation
    • 1.4.2 Key trends for market estimation
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
  • 1.6 Forecast model
  • 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

  • 2.1 Industry 3600 synopsis
  • 2.2 Key market trends
    • 2.2.1 Regional trends
    • 2.2.2 Indication trends
    • 2.2.3 End use trends
  • 2.3 CXO perspectives: Strategic imperatives
    • 2.3.1 Key decision points for industry executives
    • 2.3.2 Critical success factors for market players
  • 2.4 Future outlook and strategic recommendations

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising prevalence of cardiac arrhythmias and atrial fibrillation
      • 3.2.1.2 Advancements in remote monitoring and connectivity technologies
      • 3.2.1.3 Growing geriatric population and associated cardiac risk
      • 3.2.1.4 Favorable reimbursement policies and early diagnosis programs
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 High cost of devices and implantation procedures
      • 3.2.2.2 Limited awareness among patients and general practitioners
    • 3.2.3 Market opportunities
      • 3.2.3.1 Integration with artificial intelligence and predictive analytics
      • 3.2.3.2 Development of smart, miniaturized, and long-life devices
  • 3.3 Growth potential analysis
  • 3.4 Pricing analysis, 2024
  • 3.5 Number of implantable cardiac monitors sold (Units), 2021 - 2034
    • 3.5.1 Global
    • 3.5.2 North America
    • 3.5.3 Europe
    • 3.5.4 Asia Pacific
    • 3.5.5 Latin America
    • 3.5.6 MEA
  • 3.6 Regulatory landscape
    • 3.6.1 North America
    • 3.6.2 Europe
    • 3.6.3 Asia Pacific
    • 3.6.4 LAMEA
  • 3.7 Technological advancements
    • 3.7.1 Current technological trends
      • 3.7.1.1 Miniaturized implantable loop recorders for long-term cardiac monitoring
      • 3.7.1.2 Remote monitoring platforms enabling real-time heart rhythm data transmission
      • 3.7.1.3 Patient-friendly, minimally invasive devices improving comfort and procedural efficiency
    • 3.7.2 Emerging technologies
      • 3.7.2.1 AI-powered arrhythmia detection and predictive analytics for early diagnosis
      • 3.7.2.2 Wireless connected implantable cardiac monitors integrating smartphone and cloud platforms
      • 3.7.2.3 Smart devices with adaptive alert systems and automated clinician notifications
  • 3.8 Gap analysis
  • 3.9 Porter's analysis
  • 3.10 PESTEL analysis
  • 3.11 Future market trends
    • 3.11.1 Convergence of AI, digital health, and connected cardiac devices
    • 3.11.2 Expansion of home-based and outpatient cardiac monitoring solutions
    • 3.11.3 Growth in emerging markets with improving healthcare infrastructure

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
    • 4.3.1 Global
    • 4.3.2 North America
    • 4.3.3 Europe
    • 4.3.4 Asia Pacific
    • 4.3.5 LAMEA
  • 4.4 Competitive positioning matrix
  • 4.5 Competitive analysis of major market players
  • 4.6 Key developments
    • 4.6.1 Mergers & acquisitions
    • 4.6.2 Partnerships & collaborations
    • 4.6.3 New service type launches
    • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Indication, 2021 - 2034 ($ Mn)

  • 5.1 Key trends
  • 5.2 Atrial fibrillation (AF)
  • 5.3 Arrhythmia
  • 5.4 Bradycardia
  • 5.5 Tachycardia
  • 5.6 Other indications

Chapter 6 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

  • 6.1 Key trends
  • 6.2 Hospitals
  • 6.3 Specialized cardiac centers
  • 6.4 Ambulatory surgical centers
  • 6.5 Other end use

Chapter 7 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

  • 7.1 Key trends
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 France
    • 7.3.4 Spain
    • 7.3.5 Italy
    • 7.3.6 Netherlands
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 Australia
    • 7.4.5 South Korea
  • 7.5 Latin America
    • 7.5.1 Brazil
    • 7.5.2 Mexico
    • 7.5.3 Argentina
  • 7.6 Middle East and Africa
    • 7.6.1 South Africa
    • 7.6.2 Saudi Arabia
    • 7.6.3 UAE

Chapter 8 Company Profiles

  • 8.1 Abbott
  • 8.2 AngelMed / Avertix
  • 8.3 BIOTRONIK
  • 8.4 Boston Scientific
  • 8.5 Medtronic
  • 8.6 Vectorious Medical Technologies